Table of Contents
List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by G7 Countries: Proportion of Sarcopenia to Musculoskeletal Disorders Clinical Trials 17
Clinical Trials by Phase in G7 Countries 19
Clinical Trials in G7 Countries by Trial Status 20
Clinical Trials by E7 Countries: Proportion of Sarcopenia to Musculoskeletal Disorders Clinical Trials 22
Clinical Trials by Phase in E7 Countries 24
Clinical Trials in E7 Countries by Trial Status 25
Clinical Trials by Phase 26
In Progress Trials by Phase 27
Clinical Trials by Trial Status 28
Clinical Trials by End Point Status 30
Subjects Recruited Over a Period of Time 31
Clinical Trials by Sponsor Type 32
Prominent Sponsors 33
Top Companies Participating in Sarcopenia Therapeutics Clinical Trials 35
Prominent Drugs 36
Latest Clinical Trials News on Sarcopenia 37
Nov 20, 2019: MYOS RENS’ Fortetropin Clinical trial results to be presented by William J. Evans, Ph.D., at the International Conference on Frailty and Sarcopenia Research 37
Oct 31, 2019: Biophytis files protocol amendment to optimize the SARA-INT phase 2b clinical trial for sarcopenia 37
Oct 04, 2019: Biophytis opens 22nd clinical site in the SARA-INT phase 2b trial of Sarconeos (BIO101) for the treatment of sarcopenia 38
Clinical Trial Profile Snapshots 39
Appendix 154
Abbreviations 154
Definitions 154
Research Methodology 155
Secondary Research 155
About GlobalData 156
Contact Us 156
Source 157
Sarcopenia Therapeutics, Global, Clinical Trials by Region, 2019* 8
Sarcopenia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 10
Sarcopenia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
Sarcopenia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 12
Sarcopenia Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 13
Sarcopenia Therapeutics Clinical Trials, North America, Top Countries, 2019* 14
Sarcopenia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 15
Sarcopenia Therapeutics Clinical Trials, Central and South America, Top Countries, 2019* 16
Proportion of Sarcopenia to Musculoskeletal Disorders Clinical Trials, G7 Countries (%), 2019* 18
Sarcopenia Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19
Sarcopenia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 21
Proportion of Sarcopenia to Musculoskeletal Disorders Clinical Trials, E7 Countries (%), 2019* 23
Sarcopenia Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 24
Sarcopenia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 25
Sarcopenia Therapeutics, Global, Clinical Trials by Phase, 2019* 26
Sarcopenia Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 27
Sarcopenia Therapeutics, Global, Clinical Trials by Trial Status, 2019* 29
Sarcopenia Therapeutics Clinical Trials, Global, by End Point Status, 2019* 30
Sarcopenia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 31
Sarcopenia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 32
Sarcopenia Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 34
Sarcopenia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 35
Sarcopenia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 36
List of Figures
Sarcopenia Therapeutics, Global, Clinical Trials by Region (%), 2019* 8
Sarcopenia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
Sarcopenia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
Sarcopenia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 12
Sarcopenia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 13
Sarcopenia Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 14
Sarcopenia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 15
Proportion of Sarcopenia to Musculoskeletal Disorders Clinical Trials, G7 Countries (%), 2019* 17
Sarcopenia Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19
Sarcopenia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20
Proportion of Sarcopenia to Musculoskeletal Disorders Clinical Trials, E7 Countries (%), 2019* 22
Sarcopenia Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 24
Sarcopenia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 25
Sarcopenia Therapeutics, Global, Clinical Trials by Phase (%), 2019* 26
Sarcopenia Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 27
Sarcopenia Therapeutics, Global, Clinical Trials by Trial Status, 2019* 28
Sarcopenia Therapeutics Clinical Trials, Global, by End Point Status, 2019* 30
Sarcopenia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 31
Sarcopenia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 32
Sarcopenia Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 33
Sarcopenia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 35
Sarcopenia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 36
GlobalData Methodology 155
【免責事項】
https://www.marketreport.jp/reports-disclaimer